High-concentration monoclonal antibodies (mAbs) are gaining prominence given the compliance and cost advantages.

In advance of CPHI 2024 next month, we have compiled our pick of the sessions for BioTechniques members, alongside everything you need to know for the conference. Where? When? Who? This year’s meeting ...

Being recognized by CPHI with this prestigious award for ... to confidently advance scientific breakthroughs and introduce new therapies. With deep domain expertise in regulatory sciences ...

discussed new advancements in ADC technologies, including the role of complex chemistries. Pharmaceutical Technology® Europe spoke with Nicolas Camper, senior director—Bioconjugation Chemistry at ...

After experiencing a series of ups and downs in recent years, the biopharma contracting business is gearing up for a rebound ...

Neopac, a company based in Switzerland that provides packaging and dosing solutions for pharmaceutical, oral, and beauty care, will unveil at CPHI Milan its new mono-material barrier (MMB) mini tubes, ...

At CPHI Europe, Angela Vollstedt, global director of Cell & Gene Therapies at Novartis discussed scale up strategies for cell ...

Celebrating this pivotal milestone, IFF will spotlight its latest solutions for nitrosamine mitigation at CPHI 2024, Milan, Oct. 8-10, booth 6B10. The range includes a new portfolio of low nitrite ...